Samsung BioLogics Co (XKRX:207940) FCF Yield % : 0.39 (As of Apr. 11, 2025)

View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Samsung BioLogics Co's Trailing 12-Month Free Cash Flow is ₩281,730 Mil, and Market Cap is ₩72,526,306 Mil. Therefore, Samsung BioLogics Co's FCF Yield % for today is 0.39%.

The historical rank and industry rank for Samsung BioLogics Co's FCF Yield % or its related term are showing as below:

XKRX:207940' s FCF Yield % Range Over the Past 10 Years
Min: -2.45 Med: -0.23 Max: 1.74
Current: 0.39

During the past 11 years, the highest FCF Yield % of Samsung BioLogics Co was 1.74%. The lowest was -2.45%. And the median was -0.23%.

XKRX:207940's FCF Yield % is ranked better than
86.27% of 1500 companies
in the Biotechnology industry
Industry Median: -16.225 vs XKRX:207940: 0.39

Samsung BioLogics Co's FCF Margin % for the quarter that ended in Dec. 2024 was -14.57%.

Samsung BioLogics Co FCF Yield % Historical Data

The historical data trend for Samsung BioLogics Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co FCF Yield % Chart

Samsung BioLogics Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Yield %

Get a 7-Day Free Trial

0.10

0.06

-0.10

1.04

0.42

Samsung BioLogics Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial															3.95	1.20	0.91	0.98	-1.08

Competitive Comparison of Samsung BioLogics Co's FCF Yield %

For the Biotechnology subindustry, Samsung BioLogics Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Samsung BioLogics Co's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Samsung BioLogics Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Samsung BioLogics Co's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Samsung BioLogics Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Samsung BioLogics Co's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	281729.869	/	67544126
	=	0.42%

Samsung BioLogics Co's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-183003.631	*	4	/	67544126
	=	-1.08%

Samsung BioLogics Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Samsung BioLogics Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Samsung BioLogics Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Samsung BioLogics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

125, Cheomdan-daero, Yeonsu-gu, Incheon, KOR

Website

https://www.samsungbiologics.com

Founded in 2011, Samsung Biologics is a South Korean contract development and manufacturing organization with a global client base. Europe and the US contribute 90% of its total revenue. It provides end-to-end development and manufacturing services from cell line developments to final commercial manufacturing. As of 2023, Samsung Biologics had a total production capacity of 604,000 liters, one of the largest in the world. Its CDMO services account for 72.4% of its total revenue. The balance comes from subsidiary Samsung Bioepis, acquired in 2022. Samsung Bioepis is involved in developing and manufacturing biosimilars.

Samsung BioLogics Co Headlines

No Headlines